9 results returned.
Page   of  1

Uriel Pharmacy v. Advocate Aurora Health
District Court: Eastern District of Wisconsin    Status: Pending
Brought by Uriel Pharmacy, a self-insured employer, the federal lawsuit alleges Advocate forced insurers to enter all-or-nothing and anti-tiering and anti-steering contract terms. In addition, …
In re Mission Health Antitrust Litigation
District Court: Western District of North Carolina    Status: Pending
Originally filed in federal district court by the city of Brevard, North Carolina (City of Brevard, North Carolina v. HCA Healthcare and Mission Health System), …
Davis et al. v. HCA Healthcare and Mission Health System
District Court: North Carolina Superior Court (Buncombe County)    Status: Pending
The class action lawsuit filed in North Carolina state court against HCA Healthcare and Mission Health alleges anticompetitive practices in violation of the North Carolina …
Community Hospitals and Wellness Centers v. State of Ohio
District Court: Common Pleas Court of Williams County    Status: Decided
Ohio’s Healthcare Price Transparency Law, passed in June 2015 (HB 52) by the Ohio Legislature, has been challenged by health care providers arguing that the …
Pharmaceutical Care Management Association (PCMA) v. Mulready
District Court: District Court of Western District of Oklahoma    Status: Pending
The 2019 Oklahoma law, Patient’s Right to Pharmacy Choice Act, targets PBM conflict of interest by prohibiting higher reimbursement rates for PBM-owned pharmacies and bans …
PhRMA and BIO v. Sandoval
District Court: District of Nevada    Status: Decided
In September 2017, just three months after Nevada passed its insulin transparency law (SB 539) in June 2017 to increase transparency over the price of …
Pharmaceutical Care Management Association (PCMA) v. Rutledge
District Court: Eastern District of Arkansas    Status: Decided
Act 900 (SB 688), enacted in 2015, required disclosure of generic drug pricing and sets a floor on prices that PBMs can pay to pharmacies …
PhRMA v. David
District Court: Eastern District of California    Status: Pending
PhRMA is challenging California’s drug price transparency law SB 17 alleging that the law is unconstitutional because it violates the Commerce Clause, the First Amendment, …
Association for Accessible Medicines v. Frosh
District Court: District of Maryland    Status: Decided
In a significant victory for the pharmaceutical industry, the 4th U.S. Circuit Court of Appeals found Maryland’s landmark 2017 law (HB 631), which punishes generic …
9 results returned.
Page   of  1